1 Min Read
Nov 10 (Reuters) - Divi’s Laboratories Ltd
* Informed that USFDA completed evaluation of co’s corrective actions in response to FDA’s warning letter dated April 13 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.